Clinical Trial Page
Clinical Trial Results:
Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.
PREMATURELY ENDED
| Summary | |
EudraCT number | 2020-001243-15 |
Trial protocol | BE |
Global completion date | |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
| Results information | |
Results version number | v1(current) |
This version publication date | 03 Jan 2021 |
First version publication date | 03 Jan 2021 |
Other versions | |
Summary report(s) | 2020-001243-15Result Letter |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.